Waystar Introduces Agentic AI to Advance Toward the Autonomous Revenue Cycle

Rhea-AI Summary

Waystar (NASDAQ: WAY) introduced agentic intelligence to its cloud-native revenue-cycle platform on January 12, 2026, extending Waystar AltitudeAI capabilities. The system leverages a proprietary data network from >7.5 billion annual transactions and coverage of one in three U.S. hospital discharges to automate workflows that act, learn, and execute tasks with minimal intervention. Early results cited include $15.5 billion in prevented denials, ~40% reduction in manual correction workload, and 95% time savings in denial-related workflows. Company will discuss strategy at the J.P. Morgan Healthcare Conference on January 12, 2026.

Positive

• Prevented $15.5 billion in denials since AltitudeAI launch
• 95% time savings reported in denial-related processes
• Approximately 40% reduction in manual correction workload
• Platform uses data from >7.5 billion annual transactions
• Coverage of 1 in 3 U.S. hospital discharges feeding AI models

Negative

• None.

News Market Reaction

-8.43%

17 alerts

-8.43% News Effect

-3.5% Trough in 8 min

-$562M Valuation Impact

$6.10B Market Cap

1.0x Rel. Volume

On the day this news was published, WAY declined 8.43%, reflecting a notable negative market reaction. Argus tracked a trough of -3.5% from its starting point during tracking. Our momentum scanner triggered 17 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $562M from the company's valuation, bringing the market cap to $6.10B at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Denials prevented: $15.5 billion Annual transactions: 7.5 billion Hospital discharge coverage: One in three +4 more

7 metrics

Denials prevented $15.5 billion Claims denials prevented in under one year by Waystar AltitudeAI

Annual transactions 7.5 billion Proprietary transactions Waystar leverages annually on its platform

Hospital discharge coverage One in three Share of U.S. hospital discharges represented in Waystar’s data network

Data points analyzed 30,000 Relevant data points prioritized from a full medical record by agentic AI

Manual workload reduction 40% Early results in reducing manual correction workload for documentation

Nursing shortage horizon 2030 Health systems planning for widespread nursing shortages by this year

Time savings 95% Client time savings cited after AltitudeAI launch and adoption

Market Reality Check

Price: $30.27 Vol: Price at $34.50, volume 1...

normal vol

$30.27 Last Close

Volume Price at $34.50, volume 1,987,067 vs 20-day average 1,799,383, indicating slightly elevated trading ahead of this AI announcement. normal

Technical Shares trade below the 200-day MA of $36.94 and are 28.29% under the 52-week high of $48.11, while still 17.35% above the 52-week low of $29.40.

Peers on Argus

WAY gained 4.29% while key health information peers like HQY (-1.48%), BTSG (-4....

1 Up

WAY gained 4.29% while key health information peers like HQY (-1.48%), BTSG (-4.26%), PRVA (-0.69%) and DOCS (-2.04%) mostly traded lower, suggesting a stock-specific reaction to this AI-focused news.

Historical Context

5 past events · Latest: Dec 29 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Dec 29	Conference presentation	Positive	-0.1%	Announced CEO presentation at J.P. Morgan Healthcare Conference with webcast access.
Nov 18	Investor conferences	Positive	+1.7%	Planned participation in multiple December investor conferences and fireside chats.
Nov 18	Index inclusion	Positive	+1.7%	Joining S&P SmallCap 600 and highlighting revenue growth and AltitudeAI performance.
Oct 29	Earnings update	Positive	+0.3%	Reported Q3 2025 growth, strong margins and raised full‑year 2025 guidance ranges.
Oct 15	Governance/board	Neutral	+0.3%	External company named chairman who also serves as Waystar’s independent board chair.

Pattern Detected

Recent news—index inclusion, earnings, and AI innovations—has generally coincided with small positive price moves, with only occasional mild divergence on neutral conference items.

Recent Company History

Over the past six months, Waystar has highlighted capital markets visibility, investor outreach, and operating strength. Inclusion in the S&P SmallCap 600 and strong Q3 2025 results with raised full‑year guidance underscored growth. Multiple conference appearances have supported exposure, while governance news referenced the board chair’s external role. Reactions around these items have been modestly positive, framing today’s AI platform update as part of a continuing execution and innovation story.

Regulatory & Risk Context

Active S-3 Shelf

Shelf Active

Active S-3 Shelf Registration 2025-07-14

WAY has an effective S-3ASR filed on 2025-07-14, expiring 2028-07-14, with at least one recorded usage via a 424B7 on 2025-09-11. Specific capacity amounts are not provided in this context.

Market Pulse Summary

The stock moved -8.4% in the session following this news. A negative reaction despite this AI expans...

Analysis

The stock moved -8.4% in the session following this news. A negative reaction despite this AI expansion would contrast with earlier AI-tagged news, which has averaged moves of about 1.93% and has often skewed positive. With the stock below its $36.94 200‑day MA and still 28.29% under the 52‑week high, investors might reassess execution risk, integration of past acquisitions, or valuation. Existing registration capacity could also shape sentiment around potential future capital actions.

Key Terms

autonomous revenue cycle, clinical documentation integrity, prior authorizations, generative AI

4 terms

autonomous revenue cycle technical

"advancing its ambitious vision for industry transformation by building the autonomous revenue cycle"

An autonomous revenue cycle is a largely self-running system that handles the full sequence of billing, insurance claims, payments and follow-up tasks for healthcare services using software and automation. For investors it matters because it can cut labor costs, speed up cash collection, reduce billing errors and lower compliance risk—similar to replacing a slow, manual checkout line with an automated, faster conveyor belt that needs fewer attendants.

clinical documentation integrity medical

"Clinical documentation integrity plays a critical role in accurate reimbursement"

Clinical documentation integrity is the practice of making sure medical records accurately and completely reflect a patient’s diagnosis, treatment and outcomes, like keeping a precise blueprint for a building. It matters to investors because clear, consistent records affect how much healthcare providers are paid, their legal and regulatory risk, and reported quality measures, all of which influence revenue, cash flow and reputation.

prior authorizations medical

"Expedite prior authorizations through proactive clinical justification"

A prior authorization is a payer's advance approval required before a health plan will cover a specific medication, medical test, or procedure. For investors, it matters because these approvals affect how quickly and widely a treatment or service can be used—similar to needing a permit before opening a store—so delays or denials can reduce sales, change cost forecasts, and create uncertainty around revenue and market adoption.

generative AI technical

"industry's first generative AI capabilities targeting denial prevention and recovery"

Generative AI is a type of computer technology that can create new content, like text, images, or music, on its own. It’s important because it can produce realistic and useful material quickly, which could change how we create art, write stories, or even develop new products. Think of it as a smart robot that can invent and produce things almost like a human.

AI-generated analysis. Not financial advice.

Extends the impact of Waystar AltitudeAI, which has prevented $15.5 billion in denials in under one year

Leverages a unique combination of proprietary data from more than 7.5 billion annual transactions and one in three U.S. hospital discharges

LEHI, Utah, and LOUISVILLE, Ky., Jan. 12, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced the introduction of agentic intelligence to its cloud-native platform. This milestone expands Waystar's innovation roadmap and highlights the differentiated power of Waystar AltitudeAI™, fueled by the industry's only data network that unifies proprietary clinical, financial, and administrative intelligence at scale.

Agentic intelligence represents the next evolution of Waystar's platform. The company is advancing its ambitious vision for industry transformation by building the autonomous revenue cycle, powered by a dynamic, end-to-end agentic network that continuously acts within workflows, executes defined tasks, and learns from outcomes with minimal intervention. Fueled by more than 7.5 billion annual transactions and one in three U.S. hospital discharges, Waystar's connected AI ecosystem helps eliminate friction in healthcare payments and activates the right AI at the right time to address providers' most pressing priorities.

"Waystar AltitudeAI prevented billions of dollars in denials last year," said Matt Hawkins, Waystar Chief Executive Officer. "With that momentum, agentic AI built on an unparalleled proprietary dataset accelerates our vision for the industry's first autonomous revenue cycle platform and advances our mission to simplify healthcare payments for providers and their patients."

Waystar AltitudeAI agent-powered workflows will expand the self-learning innovation engine and unlock new capabilities and stronger client outcomes, including the following:

• Expedite prior authorizations through proactive clinical justification to ensure more accurate reimbursement
• Prevent denials through integrated documentation, coding, and charge capture revenue protection to drive faster, more predictable cash flow
• Recommend corrections automatically based on historical denial insights to create clean, accurate, and compliant claims
• Accelerate recovery through intelligence-powered clinical appeals to drive higher productivity with lower costs

Agentic Intelligence in Action

Waystar marks a meaningful milestone on the path toward the autonomous revenue cycle with a new agentic AI workflow that reduces administrative burden and will help relieve nurse burnout as health systems plan for widespread nursing shortages by 2030. This milestone represents the next step in Waystar's broader innovation roadmap, with additional agentic intelligence planned to expand automation across the revenue cycle.

Clinical documentation integrity plays a critical role in accurate reimbursement, but it creates manual work across chart review, documentation validation, and correction requests that require clinical oversight before submitting charges.

In seconds, Waystar's agentic AI analyzes the full medical record, prioritizes the most relevant 30,000 data points through advanced reasoning, and automatically pre-populates requests for correction with supporting clinical context. Early results show an approximately 40% reduction in manual correction workload, allowing providers to move faster with greater confidence and focus on higher-value clinical work.

Building on more than a decade of AI innovation, Waystar accelerated its efforts over the past year to address rising denial rates and the billions providers spend annually to combat them. Following the launch and rapid adoption of Waystar AltitudeAI, including the industry's first generative AI capabilities targeting denial prevention and recovery, Waystar clients have prevented $15.5 billion in claims that would have otherwise been denied, achieved 95% time savings, and increased denial overturn rates by double digits.

Waystar will further discuss its innovation strategy during Matt Hawkins' presentation at the J.P. Morgan Healthcare Conference on January 12, 2026.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts. The words "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "seek," "foreseeable," the negative version of these words, or similar terms and phrases are intended to identify forward-looking statements. The forward-looking statements contained in this press release are based on management's current expectations and are inherently subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. These risks and uncertainties include, but are not limited to, risks and uncertainties associated with the consummation of the offering and other risks described in Waystar's Annual Report on Form 10-K for the year ended December 31, 2024 and any subsequent filings with the SEC. Except as required by law, Waystar has no obligation to update any of these forward-looking statements to conform these statements to actual results or revised expectations.

About Waystar

Waystar's mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves over 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals list. Waystar's enterprise-grade platform annually processes over 7.5 billion healthcare payment transactions, including over $2.4 trillion in annual gross claims and spanning approximately 60% of U.S. patients and one in three U.S. hospital discharges. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at waystar.com.

Media Contact
Kristin Lee 
kristin.lee@waystar.com 

Investor Contact
investors@waystar.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/waystar-introduces-agentic-ai-to-advance-toward-the-autonomous-revenue-cycle-302658058.html

SOURCE Waystar

FAQ

What did Waystar (WAY) announce about agentic AI on January 12, 2026?

Waystar announced introduction of agentic intelligence to its cloud-native revenue-cycle platform to automate workflows and expand Waystar AltitudeAI capabilities.

How much in denied claims has Waystar helped prevent with AltitudeAI?

Clients have prevented $15.5 billion in claims that would have otherwise been denied.

What performance improvements does Waystar report from agentic AI workflows?

Early results include about a 40% reduction in manual correction workload and reported 95% time savings in denial workflows.

What data powers Waystar's agentic AI and how broad is its coverage?

Agentic AI is fueled by a proprietary network with more than 7.5 billion annual transactions and covers one in three U.S. hospital discharges.

Will Waystar discuss its agentic AI strategy publicly?

Yes. Waystar will discuss its innovation strategy during CEO Matt Hawkins' presentation at the J.P. Morgan Healthcare Conference on January 12, 2026.